Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kojiri

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Antibiotics|December 1, 1993
A new antitumor substance, BE-18591, produced by a streptomycete. II. Structure determinationS Nakajima, K Kojiri, H Suda
The Journal of Antibiotics|October 1, 1991
New antitumor substances, BE-12406A and BE-12406B, produced by a streptomycete. II. Structure determinationS Nakajima, K Kojiri, H Suda, et al.
The Journal of Antibiotics|August 1, 1990
New analogs of rosaramicin isolated from a Micromonospora strain. II. Structure determinationS Nakajima, K Kojiri, H Morishima, et al.
Oncology Reports|May 20, 2011
Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphologyY Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|June 1, 1992
A new macrocyclic lactam antibiotic, BE-14106. I. Taxonomy, isolation, biological activity and structural elucidationK Kojiri, S Nakajima, H Suzuki, et al.
Oncology Reports|May 20, 2011
Azatyrosine is incorporated into proteins instead of tyrosine residues, with the resultant conversion of transformed cells to cells with a normal phenotypeY Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|December 1, 1995
BE-24566B, a new antibiotic produced by Streptomyces violaceusnigerK Kojiri, S Nakajima, A Fuse, et al.
Oncology Reports|May 20, 2011
Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2Y Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|December 1, 1993
A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological propertiesK Kojiri, S Nakajima, H Suzuki, et al.
The Journal of Antibiotics|December 1, 1991
Endothelin-binding inhibitors, BE-18257A and BE-18257B II. Structure determinationS Nakajima, K Niiyama, M Ihara, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Antibiotics|December 1, 1993
A new antitumor substance, BE-18591, produced by a streptomycete. II. Structure determinationS Nakajima, K Kojiri, H Suda
The Journal of Antibiotics|October 1, 1991
New antitumor substances, BE-12406A and BE-12406B, produced by a streptomycete. II. Structure determinationS Nakajima, K Kojiri, H Suda, et al.
The Journal of Antibiotics|August 1, 1990
New analogs of rosaramicin isolated from a Micromonospora strain. II. Structure determinationS Nakajima, K Kojiri, H Morishima, et al.
Oncology Reports|May 20, 2011
Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphologyY Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|June 1, 1992
A new macrocyclic lactam antibiotic, BE-14106. I. Taxonomy, isolation, biological activity and structural elucidationK Kojiri, S Nakajima, H Suzuki, et al.
Oncology Reports|May 20, 2011
Azatyrosine is incorporated into proteins instead of tyrosine residues, with the resultant conversion of transformed cells to cells with a normal phenotypeY Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|December 1, 1995
BE-24566B, a new antibiotic produced by Streptomyces violaceusnigerK Kojiri, S Nakajima, A Fuse, et al.
Oncology Reports|May 20, 2011
Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2Y Monden, T Nakamura, K Kojiri, et al.
The Journal of Antibiotics|December 1, 1993
A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological propertiesK Kojiri, S Nakajima, H Suzuki, et al.
The Journal of Antibiotics|December 1, 1991
Endothelin-binding inhibitors, BE-18257A and BE-18257B II. Structure determinationS Nakajima, K Niiyama, M Ihara, et al.
Pageof 4